Literature DB >> 2541059

Endotoxin-induced hypercoagulability: a possible aggravating factor of alcoholic liver disease.

M Arai1, S Nakano, F Okuno, Y Hirano, K Sujita, T Kobayashi, H Ishii, M Tsuchiya.   

Abstract

The present experiments were designed to study the effect of chronic ethanol consumption on endotoxin toxicity. The intravenous injection of endotoxin produced a more pronounced increase of serum AST and ALT activities in chronic ethanol-fed rats, when compared to controls. The activities of hepatic mitochondrial enzymes, succinate dehydrogenase and cytochrome oxidase, were also distinctly decreased by endotoxin treatment in chronic ethanol-fed rats. Consistent with these biochemical alterations, light and electron microscopic examinations revealed severe liver injury after endotoxin injection in chronic ethanol-fed rats. Furthermore, the increase of blood BUN and creatinine levels accompanied by the degeneration of the renal tubulus and slight infiltration of neutrophils into the glomerule were produced by endotoxin treatment and were more conspicuous in chronic ethanol-fed rats than controls. Therefore, the biochemical and histological evidence indicates that endotoxin markedly potentiates organ injury after chronic ethanol consumption. In addition, a more pronounced decrease in blood antithrombin III activity accompanied by an increase in fibrin degradation product level in blood was recognized in chronic ethanol-fed rats receiving endotoxin, when compared to controls receiving endotoxin. This increase of blood fibrin degradation product level correlated well with the decrease of antithrombin III activity (r = -0.6116; p less than 0.005). These findings of blood antithrombin III activity and fibrin degradation product level indicate that the coagulation-fibrinolysis system is more activated by endotoxin treatment after chronic ethanol consumption. Furthermore, the activation of the coagulation-fibrinolysis system was well correlated with biochemical and histological alterations representing hepatorenal involvement.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2541059     DOI: 10.1002/hep.1840090609

Source DB:  PubMed          Journal:  Hepatology        ISSN: 0270-9139            Impact factor:   17.425


  6 in total

1.  Effect of lipopolysaccharides on erythrocyte flow velocity in rat liver.

Authors:  Y Horie; S Kato; E Ohki; H Hamamatsu; D Fukumura; I Kurose; H Suzuki; M Suematsu; S Miura; H Ishii
Journal:  J Gastroenterol       Date:  1997-12       Impact factor: 7.527

2.  Herbal cardiotonic pills prevent gut ischemia/reperfusion-induced hepatic microvascular dysfunction in rats fed ethanol chronically.

Authors:  Yoshinori Horie; Jing-Yan Han; Shuka Mori; Masahiro Konishi; Mikio Kajihara; Takehiko Kaneko; Yoshiyuki Yamagishi; Shinzo Kato; Hiromasa Ishii; Toshifumi Hibi
Journal:  World J Gastroenterol       Date:  2005-01-28       Impact factor: 5.742

3.  Gene expression profiling of alcoholic liver disease in the baboon (Papio hamadryas) and human liver.

Authors:  Devanshi Seth; Maria A Leo; Peter H McGuinness; Charles S Lieber; Yvonne Brennan; Rohan Williams; Xin M Wang; Geoffrey W McCaughan; Mark D Gorrell; Paul S Haber
Journal:  Am J Pathol       Date:  2003-12       Impact factor: 4.307

4.  Severity of liver injury in experimental alcoholic liver disease. Correlation with plasma endotoxin, prostaglandin E2, leukotriene B4, and thromboxane B2.

Authors:  A A Nanji; U Khettry; S M Sadrzadeh; T Yamanaka
Journal:  Am J Pathol       Date:  1993-02       Impact factor: 4.307

5.  Preservation of intestinal structural integrity by zinc is independent of metallothionein in alcohol-intoxicated mice.

Authors:  Jason C Lambert; Zhanxiang Zhou; Lipeng Wang; Zhenyuan Song; Craig J McClain; Y James Kang
Journal:  Am J Pathol       Date:  2004-06       Impact factor: 4.307

6.  The effects of insulin pre-administration in mice exposed to ethanol: alleviating hepatic oxidative injury through anti-oxidative, anti-apoptotic activities and deteriorating hepatic steatosis through SRBEP-1c activation.

Authors:  Jiangzheng Liu; Xin Wang; Zhengwu Peng; Tao Zhang; Hao Wu; Weihua Yu; Deqing Kong; Ying Liu; Hua Bai; Rui Liu; Xiaodi Zhang; Chunxu Hai
Journal:  Int J Biol Sci       Date:  2015-04-03       Impact factor: 6.580

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.